Wells Fargo & Company Collegium Pharmaceutical, Inc Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Wells Fargo & Company holds 18,333 shares of COLL stock, worth $639,638. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,333

Previous 10,989 66.83%

Holding current value

$639,638

Previous $338,000 110.36%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$31.23 - $40.91 $229,353 - $300,443	7,344 Added 66.83%	18,333 $711,000
Q4 2023 Feb 09, 2024	SELL	$21.16 - $30.8 $5,945 - $8,654	-281 Reduced 2.49%	10,989 $338,000
Q3 2023 Nov 13, 2023	SELL	$21.23 - $24.28 $190,390 - $217,743	-8,968 Reduced 44.31%	11,270 $251,000
Q2 2023 Aug 15, 2023	BUY	$21.06 - $24.0 $107,069 - $122,016	5,084 Added 33.55%	20,238 $434,000
Q1 2023 May 12, 2023	BUY	$23.0 - $29.88 $269,445 - $350,044	11,715 Added 340.65%	15,154 $363,000

Q4 2022 Feb 13, 2023	SELL	$16.14 - $23.55 $17,415 - $25,410	-1,079 Reduced 23.88%	3,439 $79,000
Q3 2022 Nov 14, 2022	SELL	$15.46 - $20.1 $3,602 - $4,683	-233 Reduced 4.9%	4,518 $72,000
Q2 2022 Aug 12, 2022	SELL	$14.22 - $20.88 $961,897 - $1.41 Million	-67,644 Reduced 93.44%	4,751 $84,000
Q1 2022 May 16, 2022	SELL	$17.2 - $22.5 $338,771 - $443,160	-19,696 Reduced 21.39%	72,395 $1.47 Million
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $716,012 - $873,535	-40,915 Reduced 30.76%	92,091 $1.72 Million
Q3 2021 Nov 15, 2021	BUY	$17.75 - $25.39 $111,967 - $160,160	6,308 Added 4.98%	133,006 $2.63 Million
Q2 2021 Aug 16, 2021	SELL	$21.74 - $25.28 $345,666 - $401,952	-15,900 Reduced 11.15%	126,698 $3 Million
Q1 2021 May 13, 2021	BUY	$19.25 - $26.1 $627,261 - $850,468	32,585 Added 29.62%	142,598 $3.38 Million
Q4 2020 Feb 09, 2021	BUY	$17.83 - $22.29 $128,732 - $160,933	7,220 Added 7.02%	110,013 $2.2 Million
Q3 2020 Nov 05, 2020	BUY	$15.78 - $20.82 $214,655 - $283,214	13,603 Added 15.25%	102,793 $2.14 Million
Q2 2020 Aug 13, 2020	BUY	$15.49 - $23.51 $204,886 - $310,966	13,227 Added 17.41%	89,190 $1.56 Million
Q1 2020 May 14, 2020	BUY	$13.89 - $25.45 $1.06 Million - $1.93 Million	75,963 New	75,963 $1.24 Million

Others Institutions Holding COLL

# of Institutions

233

Shares Held

40M

Call Options Held

104K

Put Options Held

15.4K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.19B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Collegium Pharmaceutical, Inc Transaction History